GlassScriptPhysician profile
Oscar Penate
NPI 1174799977
$4,088.92
in general payments reported to CMS, 2019-2025
13 companies · $1,139 in 2025
The $1,139 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $48.22 · 2021: $1,160 · 2022: $1,168 · 2023: $235 · 2024: $236 · 2025: $1,139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $925 · Food and Beverage: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $925.47 |
| Food and Beverage | $685.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,188.59 | 2021-2025 | Triclip, Mitraclip |
| Boston Scientific Corporation | $1,270.46 | 2022-2024 | Watchman Flx |
| Atricure, INC. | $155.31 | 2023 | |
| Edwards Lifesciences Corporation | $141.35 | 2019-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Abiomed | $102.97 | 2024-2025 | Impella |
| Livanova USA, INC. | $70.56 | 2019 | |
| Phathom Pharmaceuticals, INC. | $36.59 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $30.72 | 2019-2025 | Bridion |
| Medtronic, INC. | $27.78 | 2022-2024 | Invos |
| Teleflex LLC | $23.33 | 2020 | |
| Conmed Corporation | $14.79 | 2024 | Visiclear |
| Getinge USA Sales, LLC | $13.67 | 2025 | Vasoview Hemopro 2 |
| Silk Road Medical, INC. | $12.80 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Penate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.